Peanut Allergy
Toothpaste provides oral mucosal immunotherapy for peanut allergy
WASHINGTON — Adults with peanut allergy safely used toothpaste infused with peanut protein as oral mucosal immunotherapy, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Q&A: Omalizumab a ‘paradigm shift’ in treating food allergy
Patients with food allergy who used omalizumab experienced increased thresholds for reacting to peanut and other foods to which they were allergic, according to a study published in The New England Journal of Medicine.
Omalizumab increases thresholds for reactions in multiple food allergies
WASHINGTON — Omalizumab increased thresholds for reacting to peanut and other common allergenic foods during accidental exposure, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Q&A: Omalizumab provides protective effect for multiple food allergies
WASHINGTON — Patients with multiple food allergies experienced a protective effect against allergic reactions with omalizumab, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Uber Eats forgets – and then remembers – that food allergies are no joke
Last week, a preview of the planned Uber Eats Super Bowl commercial, “Don’t Forget,” sparked condemnation from the food allergy community regarding the depiction of an adult having an allergic reaction to the ingestion of peanut butter.
Top in allergy/asthma: Disinfectants affect asthma; rates of new peanut allergies are low
More frequent use of household cleaning products led to higher odds of current or uncontrolled asthma. The highest odds were associated with the use of disinfectant wipes, according to a recent study.
Top news of January: Dupilumab for eosinophilic esophagitis, cell phone allergy, more
Healio compiled the most-read news in allergy, asthma and immunology posted in January.
Success limited in oral immunotherapy for adults with food allergies
Adults experienced limited success with oral immunotherapy for food allergies, with about half of a cohort halting treatment within 2 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Top in allergy/asthma: Anaphylaxis at work; some kids avoid peanuts despite negative test
Insect venom was the cause of 82.7% of cases of occupational anaphylaxis, followed by food, drugs and latex, according to a study published in Allergy.
Peanut introduction largely successful among cohort of high-risk infants
Researchers found low rates of new peanut allergy and generally low rates of peanut discontinuation after introduction in a cohort of high-risk infants, according to study results published in The Journal of Allergy and Clinical Immunology.